
    
      Registry criteria: Patients treated in the investigators hospital using teriparatide.
      Enrolled patients are severe osteoporosis; more than two previous osteoporotic fractures, low
      BMD (< young adult mean 65%).

      Interventions: blood analyses and dual-energy X-ray absorptiometry (DXA) every 4 months
      Informed consent: Written informed consent will be obtained. Sample size: Five-hundreds
      participants
    
  